主動脈及血管移植設備市場:開發平台(管線)報告(開發階段，市場區隔，地區·國家，法規途徑，主要企業)，2024年版

支氣管鏡是一種微創診斷醫療設備，用於檢查氣管和近端支氣管。透過鼻子或嘴巴引入支氣管鏡以觀察支氣管的遠端分支。

本報告提供主動脈及血管移植設備市場相關調查，提供產品概要與正在開發的開發中產品趨勢，各種處於開發階段的產品比較分析和進行中的臨床試驗相關資訊，參與企業的最近趨勢等資訊。

目錄

第1章 目錄

第2章 簡介

• 主動脈及血管移植設備概要

第3章 開發中的產品

• 主動脈及血管移植設備 - 各開發階段平台產品
• 主動脈及血管移植設備 - 各地區開發中產品
• 主動脈及血管移植設備 - 各法規途徑開發中產品
• 主動脈及血管移植設備 - 估計核准日開發中產品
• 主動脈及血管移植設備 - 進行中的臨床試驗

第4章 主動脈及血管移植設備- 各公司正在開發的開發中產品

• 主動脈及血管移植設備企業- 各開發階段的開發中產品
• 主動脈及血管移植設備- 各開發階段的開發中產品

第5章 主動脈及血管移植設備企業與產品概要

• Acro Biomedical Co Ltd
• BioLife4D Corp
• Cook Medical Inc
• Drexel University
• Endomimetics LLC
• Endoron Medical Ltd
• Humacyte Inc
• Innoventric Ltd
• Merit Medical Systems Inc
• Shanghai MicroPort Endovascular MedTech Group Co Ltd
• Stanford University
• Strait Access Technologies(Pty)Ltd
• University of Toledo
• Vascular Graft Solutions Ltd
• Verigraft AB

第6章 主動脈及血管移植設備-最近的趨勢

第7章 附錄

GlobalData's Medical Devices sector report, "Aortic and Vascular Graft Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Aortic and Vascular Graft Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Aortic Stent grafts are used to reinforce a weaken aorta to prevent ruptures. Vascular grafts are tubes made up of natural tissue or synthetic materials surgically implanted in the veins and arteries.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the Aortic and Vascular Graft Devices under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Aortic and Vascular Graft Devices and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Aortic and Vascular Graft Devices under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Aortic and Vascular Graft Devices Overview

3 Products under Development

• 3.1 Aortic and Vascular Graft Devices - Pipeline Products by Stage of Development
• 3.2 Aortic and Vascular Graft Devices - Pipeline Products by Territory
• 3.3 Aortic and Vascular Graft Devices - Pipeline Products by Regulatory Path
• 3.4 Aortic and Vascular Graft Devices - Pipeline Products by Estimated Approval Date
• 3.5 Aortic and Vascular Graft Devices - Ongoing Clinical Trials

4 Aortic and Vascular Graft Devices - Pipeline Products under Development by Companies

• 4.1 Aortic and Vascular Graft Devices Companies - Pipeline Products by Stage of Development
• 4.2 Aortic and Vascular Graft Devices - Pipeline Products by Stage of Development

5 Aortic and Vascular Graft Devices Companies and Product Overview

• 5.1 Acro Biomedical Co Ltd Company Overview
  • 5.1.1 Acro Biomedical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.2 BioLife4D Corp Company Overview
  • 5.2.1 BioLife4D Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.3 Cook Medical Inc Company Overview
  • 5.3.1 Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.4 Drexel University Company Overview
  • 5.4.1 Drexel University Pipeline Products & Ongoing Clinical Trials Overview
• 5.5 Endomimetics LLC Company Overview
  • 5.5.1 Endomimetics LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.6 Endoron Medical Ltd Company Overview
  • 5.6.1 Endoron Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.7 Humacyte Inc Company Overview
  • 5.7.1 Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.8 Innoventric Ltd Company Overview
  • 5.8.1 Innoventric Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.9 Merit Medical Systems Inc Company Overview
  • 5.9.1 Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.10 Shanghai MicroPort Endovascular MedTech Group Co Ltd Company Overview
  • 5.10.1 Shanghai MicroPort Endovascular MedTech Group Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.11 Stanford University Company Overview
  • 5.11.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview
• 5.12 Strait Access Technologies (Pty) Ltd Company Overview
  • 5.12.1 Strait Access Technologies (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.13 University of Toledo Company Overview
  • 5.13.1 University of Toledo Pipeline Products & Ongoing Clinical Trials Overview
• 5.14 Vascular Graft Solutions Ltd Company Overview
  • 5.14.1 Vascular Graft Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.15 Verigraft AB Company Overview
  • 5.15.1 Verigraft AB Pipeline Products & Ongoing Clinical Trials Overview

6 Aortic and Vascular Graft Devices- Recent Developments

• 6.1 Apr 24, 2024: Meihua International Medical Technologies Reports 2023 Financial Year Results
• 6.2 Mar 29, 2024: MicroPort CardioFlow Medtech Full Year 2023 Earnings
• 6.3 Oct 31, 2023: Meihua International Medical Technologies, Establishes A Subsidiary Dedicated to Introducing International Patented Pharmaceuticals and Medical Device
• 6.4 Oct 16, 2023: Humacyte Publishes Preclinical Results Showing Human Acellular Vessel (HAV) Patency as Modified Blalock-Taussig-Thomas Shunt in Juvenile Primate Model
• 6.5 Oct 15, 2023: Shanghai Kindly Medical Instruments Co. Notice of 2023 First Extraordinary General Meeting
• 6.6 Oct 05, 2023: Shanghai Kindly Medical Instruments Co. Announces 2022 Annual Report
• 6.7 Oct 02, 2023: Swedish Personalized Tissue Graft Company Verigraft Reports Promising Interim Results From a First-In-Man Study in Patients With Deep Venous Insufficiency at 2023 Cell & Gene Meeting on the Mesa
• 6.8 Aug 29, 2023: MicroPort CardioFlow Medtech Corp. Announces Change of Directors and Chairman
• 6.9 Aug 29, 2023: Microport Cardioflow Medtech Announces Change of Directors and Chairman
• 6.10 May 18, 2023: Shanghai Kindly Medical Instruments Co. Announces Poll Results of Annual General Meeting & Payment of Final Dividend

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us
• 7.4 Disclaimer

List of Tables

• Aortic and Vascular Graft Devices - Pipeline Products by Stage of Development
• Aortic and Vascular Graft Devices - Pipeline Products by Territory
• Aortic and Vascular Graft Devices - Pipeline Products by Regulatory Path
• Aortic and Vascular Graft Devices - Pipeline Products by Estimated Approval Date
• Aortic and Vascular Graft Devices - Ongoing Clinical Trials
• Aortic and Vascular Graft Devices Companies - Pipeline Products by Stage of Development
• Aortic and Vascular Graft Devices - Pipeline Products by Stage of Development
• Acro Biomedical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• ACROARTERY - Product Status
• ACROARTERY - Product Description
• BioLife4D Corp Pipeline Products & Ongoing Clinical Trials Overview
• Cardiac Graft - Product Status
• Cardiac Graft - Product Description
• Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
• Zenith Eterna - Product Status
• Zenith Eterna - Product Description
• Drexel University Pipeline Products & Ongoing Clinical Trials Overview
• Hydrogel-Based Chemically-Eluting Shunt Prosthesis - Product Status
• Hydrogel-Based Chemically-Eluting Shunt Prosthesis - Product Description
• Endomimetics LLC Pipeline Products & Ongoing Clinical Trials Overview
• Stent Graft - Product Status
• Stent Graft - Product Description
• Endoron Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
• Aortoseal - Product Status
• Aortoseal - Product Description
• Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview
• Humacyl Graft - Pediatric Heart Surgery - Product Status
• Humacyl Graft - Pediatric Heart Surgery - Product Description
• Innoventric Ltd Pipeline Products & Ongoing Clinical Trials Overview
• Trillium - Product Status
• Trillium - Product Description
• Innoventric Ltd - Ongoing Clinical Trials Overview
• Trillium - Early Feasibility Study (EFS) to Assess the Safety and Performance of the Innoventric Trillium Stent Graft in the Treatment of Severe or Greater Tricuspid Regurgitation (TR)
• Trillium - Prospective, Single Arm, Multi-center, First-in-human (FIH) Study to Assess the Safety and Performance of the Innoventric Trillium Stent Graft for the Treatment of Severe Tricuspid Regurgitation (TR)
• Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
• WRAPSODY Endovascular Stent Graft - Venous Occlusive Disease - Product Status
• WRAPSODY Endovascular Stent Graft - Venous Occlusive Disease - Product Description
• Merit Medical Systems Inc - Ongoing Clinical Trials Overview
• WRAPSODY Endovascular Stent Graft - Venous Occlusive Disease - Prospective, Randomized, Controlled, Multicenter Study Comparing the Merit WRAPSODY Endovascular Stent Graft to Percutaneous Transluminal Angioplasty for Treatment of Venous Outflow Circuit Stenosis or Occlusion in Hemodialysis Patients: The WAVE Study
• Shanghai MicroPort Endovascular MedTech Group Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• Aortic Vascular Intervention Device - Product Status
• Aortic Vascular Intervention Device - Product Description
• Stanford University Pipeline Products & Ongoing Clinical Trials Overview
• Geometric Aortic Graft - Product Status
• Geometric Aortic Graft - Product Description
• Strait Access Technologies (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview
• TEVAR/EVAR Molding Balloon - Product Status
• TEVAR/EVAR Molding Balloon - Product Description
• University of Toledo Pipeline Products & Ongoing Clinical Trials Overview
• Aortic Endograft Fenestration Device - Product Status
• Aortic Endograft Fenestration Device - Product Description
• Vascular Graft Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview
• VEST - Product Status
• VEST - Product Description
• Vascular Graft Solutions Ltd - Ongoing Clinical Trials Overview
• VEST - A Multi-center, Randomized, Within-subject-controlled, Open Label Study of the Safety and Effectiveness of VEST, Venous External Support
• Verigraft AB Pipeline Products & Ongoing Clinical Trials Overview
• P-TEV - Product Status
• P-TEV - Product Description
• Verigraft AB - Ongoing Clinical Trials Overview
• P-TEV - Phase I Open-label, First-in-human Study to Evaluate Feasibility and Safety of Tissue Engineered Veins in Patients With Chronic Venous Insufficiency
• Glossary

List of Figures

• Aortic and Vascular Graft Devices - Pipeline Products by Stage of Development
• Aortic and Vascular Graft Devices - Pipeline Products by Territory
• Aortic and Vascular Graft Devices - Pipeline Products by Regulatory Path
• Aortic and Vascular Graft Devices - Pipeline Products by Estimated Approval Date
• Aortic and Vascular Graft Devices - Ongoing Clinical Trials